Round J - Search Results

1

Imatinib as adjuvant treatment following resection of KIT-positive gastrointestinal stromal tumours.

Dretzke J, Round J, Connock M, Tubeuf S, Pennant M, Fry-Smith A, Hulme C, McCabe C, Meads C. Dretzke J, et al. Among authors: round j. Health Technol Assess. 2010 Oct;14(Suppl. 2):63-70. doi: 10.3310/hta14suppl2/09. Health Technol Assess. 2010. PMID: 21047493 Free article. Review.

2

Cetuximab for the first-line treatment of metastatic colorectal cancer.

Meads C, Round J, Tubeuf S, Moore D, Pennant M, Bayliss S. Meads C, et al. Among authors: round j. Health Technol Assess. 2010 May;14 Suppl 1:1-8. doi: 10.3310/hta14Suppl1/01. Health Technol Assess. 2010. PMID: 20507797 Free article. Review.

3

Sorafenib for the treatment of advanced hepatocellular carcinoma.

Connock M, Round J, Bayliss S, Tubeuf S, Greenheld W, Moore D. Connock M, et al. Among authors: round j. Health Technol Assess. 2010 May;14 Suppl 1:17-21. doi: 10.3310/hta14Suppl1/03. Health Technol Assess. 2010. PMID: 20507799 Free article. Review.

4

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia.

Edlin R, Connock M, Tubeuf S, Round J, Fry-Smith A, Hyde C, Greenheld W. Edlin R, et al. Among authors: round j. Health Technol Assess. 2010 May;14 Suppl 1:69-74. doi: 10.3310/hta14Suppl1/10. Health Technol Assess. 2010. PMID: 20507806 Free article. Review.

5

Cost-effectiveness analysis and efficient use of the pharmaceutical budget: the key role of clinical pharmacologists.

Edlin R, Round J, Hulme C, McCabe C. Edlin R, et al. Among authors: round j. Br J Clin Pharmacol. 2010 Sep;70(3):350-5. doi: 10.1111/j.1365-2125.2010.03617.x. Br J Clin Pharmacol. 2010. PMID: 20716234 Free PMC article.

6

Economic considerations in the provision of treatments for rare diseases.

McCabe C, Edlin R, Round J. McCabe C, et al. Among authors: round j. Adv Exp Med Biol. 2010;686:211-22. doi: 10.1007/978-90-481-9485-8_13. Adv Exp Med Biol. 2010. PMID: 20824448 Review.

7

Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis.

Connock M, Tubeuf S, Malottki K, Uthman A, Round J, Bayliss S, Meads C, Moore D. Connock M, et al. Among authors: round j. Health Technol Assess. 2010 Oct;14(Suppl. 2):1-10. doi: 10.3310/hta14suppl2/01. Health Technol Assess. 2010. PMID: 21047485 Free article. Review.

8

A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease.

Dretzke J, Edlin R, Round J, Connock M, Hulme C, Czeczot J, Fry-Smith A, McCabe C, Meads C. Dretzke J, et al. Among authors: round j. Health Technol Assess. 2011 Feb;15(6):1-244. doi: 10.3310/hta15060. Health Technol Assess. 2011. PMID: 21291629 Free PMC article. Review.

9

Updated cost-effectiveness analysis of trastuzumab for early breast cancer: a UK perspective considering duration of benefit, long-term toxicity and pattern of recurrence.

Hall PS, Hulme C, McCabe C, Oluboyede Y, Round J, Cameron DA. Hall PS, et al. Among authors: round j. Pharmacoeconomics. 2011 May;29(5):415-32. doi: 10.2165/11588340-000000000-00000. Pharmacoeconomics. 2011. PMID: 21504241

10

Urinary tract infections in children and the risk of ESRF.

Round J, Fitzgerald AC, Hulme C, Lakhanpaul M, Tullus K. Round J, et al. Acta Paediatr. 2012 Mar;101(3):278-82. doi: 10.1111/j.1651-2227.2011.02542.x. Epub 2011 Dec 16. Acta Paediatr. 2012. PMID: 22122273 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

296 results

Search Page

Filters